Our Services
Medical Information
Helpful Resources
Published on: 9/17/2026
Taking ashwagandha at night alongside a statin is generally considered low risk for most people, but there are important cautions to weigh, including possible liver enzyme changes, added sedation, and effects on thyroid hormone, blood sugar, and blood pressure. Because both statins and ashwagandha are processed by the liver, anyone with liver conditions, thyroid disease, autoimmune disorders, or who is pregnant should not combine them without medical guidance. Signs that warrant prompt attention include yellowing skin or eyes, dark urine, unusual fatigue, upper right abdominal pain, or new muscle pain and weakness. Several factors, including dose, timing, and your other medications, change the answer for each individual, so see below to understand more before starting or continuing this combination.
If you are unsure whether your symptoms are from the supplement, the statin, or something unrelated, a free, instant, online symptom check can help you sort through your specific situation in minutes and point you toward the right next step, whether that is adjusting your routine or speaking with a clinician.
Last reviewed for medical accuracy: 09/17/2026
Ashwagandha and Heart Medication Safety: Can You Take Ashwagandha at Night with Your Statin?
Many people turn to herbal supplements like ashwagandha for stress relief, better sleep or muscle recovery. If you’re also taking a statin for high cholesterol, you may wonder: is it safe to take ashwagandha at night alongside your heart medication? Here’s a balanced, research-based look at potential interactions, benefits, risks and practical tips—without inducing unnecessary worry.
Ashwagandha (Withania somnifera) is an adaptogenic herb used for centuries in Ayurvedic medicine. Modern studies suggest it can:
Because of these benefits, many people prefer taking it in the evening to promote relaxation and deeper rest.
Statins (e.g., atorvastatin, simvastatin, rosuvastatin) lower “bad” LDL cholesterol by blocking HMG-CoA reductase in the liver. They remain among the most prescribed heart medications and have a well-established safety profile when used correctly.
When considering ashwagandha and heart medication safety, the main concern is whether the herb alters how your statin is absorbed, metabolized or excreted. Two key pathways matter:
Overall, credible resources like MedlinePlus and the Mayo Clinic note that ashwagandha-statin interactions remain theoretical and haven’t been flagged as clinically significant in healthy adults.
These potential advantages arise partly because ashwagandha can help regulate the body’s stress-response system (the hypothalamic-pituitary-adrenal axis).
While serious interactions seem unlikely, be aware of:
Statins can also cause muscle aches (myalgia). If you experience worsening muscle pain after adding ashwagandha, note it, as both the herb and statins have been linked to rare muscle effects.
Until large-scale studies confirm safety in statin–ashwagandha co-administration, recommendations rely on current human data and in vitro findings.
For anything life-threatening or serious, always speak to a doctor or seek emergency care immediately.
Summary
If you ever feel uncertain about new symptoms, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker (https://ubiehealth.com/). And always speak to a doctor before making changes to your medication or supplement regimen—especially if you have underlying health conditions or are taking multiple prescriptions. Your physician can provide personalized advice to keep both your heart and overall health on track.
(References)
* Çakici N, van Beveren NJM, Judge-Hundal G, Koola MM, Sommer IEC. An update on the efficacy of anti-inflammatory agents for patients with schizophrenia: a meta-analysis. Psychol Med. 2019 Oct;49(14):2307-2319. doi: 10.1017/S0033291719001995. Epub 2019 Aug 23. PMID: 31439071; PMCID: PMC6763537.
* Zhang L, Shi Y, Yan M, Zhang G. Modulatory action of withaferin-A on oxidative damage through regulation of inflammatory mediators and apoptosis via PI3K/AKT signaling pathway in high cholesterol-induced atherosclerosis in experimental rats. J Biochem Mol Toxicol. 2022 Oct;36(10):e23154. doi: 10.1002/jbt.23154. Epub 2022 Jun 23. PMID: 35734936.
* Azmi MB, Khan F, Asif U, Khurshid B, Wadood A, Qureshi SA, Ahmed SDH, Mudassir HA, Sheikh SI, Feroz N. In Silico Characterization of Withania coagulans Bioactive Compounds as Potential Inhibitors of Hydroxymethylglutaryl (HMG-CoA) Reductase of Mus musculus. ACS Omega. 2023 Feb 7;8(5):5057-5071. doi: 10.1021/acsomega.2c07893. Epub 2023 Jan 30. PMID: 36777558; PMCID: PMC9909811.
* Bilal Azmi M, Khan F, Asif U, Hoda F, Arslan Sehgal S, A Qureshi S, Haseen Ahmed SD. Computational exploration of Withania coagulans-derived natural inhibitors targeting HMG-CoA reductase: A pharmacokinetic, docking and molecular dynamics study for cholesterol regulation in Mus musculus. Pak J Pharm Sci. 2026 Apr;39(4):999-1020. doi: 10.36721/PJPS.2026.39.4.REG.14438.1. PMID: 41761798.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.